Sarah Nemec's most recent trade in Bolt Biotherapeutics Inc was a trade of 4,077 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on Sept. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 16 Sep 2026 | 4,077 | 17,082 | - | 3.2 | 13,195 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.32 per share. | 16 Sep 2026 | 2,922 | 21,159 | - | 3.3 | 9,696 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.77 per share. | 16 Sep 2026 | 843 | 24,081 | - | 3.8 | 3,181 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 16 Sep 2026 | 509 | 1,924 | - | 3.9 | 1,973 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 28 Jan 2026 | 8,000 | 8,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 4.61 per share. | 28 Jan 2026 | 125 | 1,415 | - | 4.6 | 576 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 11,299 | 11,299 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 11,299 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 6,699 | 6,699 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 6,699 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 4,499 | 4,499 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 4,499 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 2,499 | 2,499 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 2,499 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 2,199 | 2,199 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 2,199 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 1,589 | 1,589 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 1,589 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 1,236 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 1,236 | 1,236 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 600 | 600 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 600 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 375 | 375 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 12 Dec 2025 | 375 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2025 | 23,000 | 23,943 | - | 0 | Common Stock | |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 24 Oct 2025 | 125 | 943 | - | 5.5 | 687 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | 01 May 2025 | 226,000 | 226,000 | - | - | Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 01 May 2025 | 2,500 | 13,863 | - | 0.6 | 1,594 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 01 May 2025 | 2,500 | 16,633 | - | 0.5 | 1,241 | Common Stock |
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | VP, Finance and PAO | 23 Jul 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Ms. Sarah Nemec | VP, Finance and PAO | 23 Jul 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |